Related Experiment Videos
[Soluble T-cell-membrane molecules; a measure for in-vivo T-cell activation]
1Centraal Laboratorium voor de Bloedtransfusiedienst van het Nederlandse Rode Kruis, Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|July 25, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Treatment of MOG antibody associated disorders: results of an international survey.
Journal of neurology·2020
The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults.
Multiple sclerosis (Houndmills, Basingstoke, England)·2019
Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
European journal of neurology·2018
No excess of autoimmune diseases in multiple sclerosis families from the Netherlands.
Acta neurologica Scandinavica·2018
Disease course after clinically isolated syndrome in children versus adults: a prospective cohort study.
European journal of neurology·2016
[Marchiafava-Bignami disease: an alcoholic with reduced consciousness and muscle paratonia].
Nederlands tijdschrift voor geneeskunde·2026
[Looking back on the COVID-19 pandemic: what explains the excess mortality due to COVID-19 in The Netherlands?]
Nederlands tijdschrift voor geneeskunde·2026
[Herbs, vitamins, and minerals during anticancer treatment].
Nederlands tijdschrift voor geneeskunde·2026
[The surgical treatment of scapular fractures].
Nederlands tijdschrift voor geneeskunde·2026
[A girl with a unilateral rash].
Nederlands tijdschrift voor geneeskunde·2026
[A teenager with chest pain].
Nederlands tijdschrift voor geneeskunde·2026
Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.
Frontiers in oncology·2026